Prognostic value of rising mean platelet volume during hospitalization in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Table 2 The laboratory findings of study population

Variable	Survivor (n = 370)	Non-survivor (n = 110)	P value
Total cholesterol (mg/dl)	181 ± 43	163 ± 39	0.001
SCr^a _adm (mg/dl)	0.86 (0.76–1.02)	0.95 (0.80–1.26)	0.048
Hemoglobin (g/dl)	14.0 ± 1.2	13.2 ± 2.2	< 0.001
WBC count (10³/mm³)	12 ± 4	12 ± 5	0.781
Platelets _adm(10³/mm³)	273 ± 78	271 ± 93	0.846
Platelets _48-72h (10³/mm³)	241 ± 73	235 ± 90	0.448
MPV _adm ((fL)	9.0 ± 1.6	9.0 ± 1.3	0.648
MPV_48-72h (fL)	9.4 ± 1.6	9.8 ± 1.4	0.035
ΔMPV^a (fL)	0.37 (− 0.1–0.89)	0.79 (0.30–1.40)	< 0.001
LVEF (%)	45 ± 9	41 ± 10	< 0.001

Abbreviations: LVEF left ventricular ejection fraction, SCr serum creatinine at admission, MPV mean platelet volume, ΔMPV change in mean platelet volume, WBC; white blood cell
^aComparison was made using Mann-Whitney U test at P < 0.05, and these values were described by median with inter-quartile range (25th and 75th percentile)

ISSN: 1471-2261